Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-13 · accession 0001209191-23-037582 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-15 | 2023-06-13+ | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 842.9K | +10% | +$166.5K |
| DM | 2023-06-15 | 2023-06-13+ | RXRX | Secora Michael | CFO | S - Sale+OE | $10.00 | -50.0K | 817.9K | -6% | -$500.0K |
| DM | 2023-06-15 | 2023-06-13+ | RXRX | Secora Michael | CFO | M - OptEx | $0.00 | -75.0K | 745.3K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-13 | M | A | 37,500 | $2.22 | 830,413 | D | — | — | (F2) Includes 2,754 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 22, 2023. |
| 2 | Common | Class A Common Stock | 2023-06-13 | S | D | 25,000 | $9.93 | 805,413 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $9.59 to $10.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2023-06-14 | S | D | 25,000 | $10.07 | 817,913 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $9.63 to $10.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2023-06-14 | M | A | 37,500 | $2.22 | 842,913 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-06-13 | M | D | 37,500 | $0.00 | 782,813 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F5) The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-06-14 | M | D | 37,500 | $0.00 | 745,313 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F5) The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. |